2020. Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s55. DOI:https://doi.org/10.25251/skin.4.supp.54.